Effects of Oxymatrine on Epidermal Differentiation Complex–Related Genes in Psoriasis Patients
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/2672010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 11.07.2026. Verfasst von Mi Rao und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Using full‐length transcriptome sequencing, psoriasis area and severity index (PASI) scores, and weighted gene coexpression network analysis, we previously constructed the coexpression network of psoriasis under oxymatrine intervention. This study delves deeper into the therapeutic mechanism of oxymatrine in psoriasis management.
Objective
To determine the effects of oxymatrine on epidermal differentiation complex (EDC)–related genes in psoriasis.
Methods
We analyzed the coexpression module best correlated with PASI scores from our previous research. Top 200 gene interactions among 11,175 gene pairs were examined in Cytoscape. SPRR2D , S100A15 , and S100A7 expressions in skin samples were verified using immunohistochemistry and quantitative reverse transcription polymerase chain reaction, and their association with PASI scores was analyzed. Discarded healthy skin samples from 5 cosmetic surgery patients served as normal controls.
Results
Cytoscape analysis revealed 59 significant genes, including 10 EDC‐related genes. SPRR2D and S100A15 expressions before treatment were higher than those among the normal controls and decreased after treatment ( p < 0.0001 for both). After treatment, SPRR2D expression remained higher than the control level ( p < 0.01), while S100A15 expression was similar to the control level ( p > 0.05). S100A7 mRNA expression before treatment was higher than the normal control expression ( p < 0.001); after treatment, the expression decreased ( p < 0.001) and approached normal ( p > 0.05). Δ SPRR2D , Δ S100A15 , and Δ S100A7 expressions were correlated with ΔPASI scores before and after treatment ( r = 0.9396, 0.9555, 0.9931, respectively; p < 0.05).
Conclusion
Oxymatrine improves psoriasis symptoms by regulating EDC‐related genes. Trial Registration: Chinese Registry of Clinical Trials: ChiCTR‐TRC‐14004301
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Rao, M., Xue, X., Qi, W., Cai, W., Wang, X., & Shi, H. (2026). Effects of Oxymatrine on Epidermal Differentiation Complex–Related Genes in Psoriasis Patients. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/2672010
Vancouver
Rao M, Xue X, Qi W, Cai W, Wang X, Shi H. Effects of Oxymatrine on Epidermal Differentiation Complex–Related Genes in Psoriasis Patients. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/2672010
BibTeX
@article{Rao2026,
author = {Rao, Mi and Xue, Xiaoxiao and Qi, Wenjing and Cai, Wenbo and Wang, Xiaohan and Shi, Huijuan},
title = {Effects of Oxymatrine on Epidermal Differentiation Complex–Related Genes in Psoriasis Patients},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/2672010}
}
EUVIMED